Imunon, Inc.
IMNN· Nasdaq
IMNNImunon, Inc.
Filed Mar 28, 2024 · 10-K · 88 days after period end · 0001493152-24-011616
derived · Computed from the longer spans the company filed.
| Metric | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures |
|---|---|---|---|---|
| Revenue | — | $125.00K | $125.00K | $125.00K |
| Net Income | -$4.89M | -$13.23M | -$4.22M | -$3.01M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Imunon, Inc. · CIK 749647 · Engraved from SEC EDGAR
ended Dec 31, 2023 · filed Mar 28, 2024 · 88 d after period end
